Dr. Brooke Reiter Glessing, MD

Dr. Glessing practices at Digestive Health Center - Akron in Akron, Ohio.

Dr. Glessing's NPI, 1447499819, was assigned on February 9, 2009. Dr. Glessing holds Ohio license 35-124313.

Dr. Glessing's primary practice is Digestive Health Center - Akron, at 570 White Pond Drive, Suite 150, Akron, OH 44320. The practice phone is (330) 869-0178.

Dr. Glessing's primary practice is Digestive Health Center - Akron in Akron, Ohio. Dr. Glessing is also affiliated with Summa Health System - Akron Campus. The medical group on file is University Eyecare. Dmand AI also links Dr. Glessing to 3 more hospitals and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glessing practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Glessing's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Glessing's licenses on file in 2 states: Ohio and Minnesota.

CMS data shows 168 Medicare services from Dr. Glessing across 6 procedure codes in 2024, for 156 Medicare patients. Medicare paid $15,189 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 156 Medicare patients who saw Dr. Glessing in 2024. The largest group is 65 to 74, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Glessing's median patient age at 63, with 67% women.

In 2024, Dr. Glessing wrote 192 Medicare Part D claims for 72 patients. 88% of them were for generic drugs. CMS names the drug for 95 of them, across 5 drugs with 11 or more claims each, at $2,126 in total drug cost. In 2023, CMS named 86 claims across 6 drugs.

Dr. Glessing accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 110 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Glessing, more than 78% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Glessing, published from 2014 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Stents, Anastomosis, Surgical and Drainage. Dr. Glessing has published most often in Gastrointest Endosc. Dr. Glessing's most frequent co-authors are Mustafa Atiq Arain, MD, Martin L. Freeman, MD and Rajeev Attam, MD.

CMS Open Payments shows 182 general payments to Dr. Glessing from 28 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Boston Scientific Corporation paid the most, $15,255.